WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
7 Minnesotans accused in massive scheme to defraud pandemic food program to stand trialNvidia to buy Israeli AI company for estimated $700MStudents in UK wowed by timeUS opens investigation into Ford crashes involving Blue Cruise partially automated driving systemSpanish city of Barcelona celebrates day of books and loveUN human rights chief condemns killings of women and children in RafahMusic and martial arts witness ChinaProgram to boost cultural exchanges between China and FranceIn Paris, students inspired by proOverseas Chinese history museum opens new branch in S. China